Clinical trial
A randomised controlled multicenter trial assessing the efficacy and safety of mesalazine therapy in patients with irritable bowel syndrome.
The primary end point of the study will be to assess the effect of mesalazine treatment on the weekly abdominal discomfort or pain of IBS patients.
| Category | Value |
|---|---|
| Study start date | 2007-11-09 |